Advertisement

Advertisement

Advertisement
  • India News

    South India to remain indifferent to national parties
    South India to remain indifferent to national parties
    If the outcomes of various elections over the past few decades, till the recent Assembly polls in Tamil Nadu and Kerala are any indication, south of the Vindhyas, the electoral arena remains a minefield for mainstream national parties, read the BJP and Congress.
    Vaccinated & Covid-recovered tests positive for Delta+
    Vaccinated & Covid-recovered tests positive for Delta+
    In the first case of Delta positive in Rajasthan, a 65-year-old woman, who recovered from Covid-19 in May and had undergone both doses of vaccination, has tested positive with the variant.
    India's Vaccination Can't Protect From Third Wave
    India's Vaccination Can't Protect From Third Wave
    The pace at which the vaccinations are happening in India is so slow that it cannot save the nation from the upcoming third wave, as per some experts in the field.
    Covid Handling India's Gravest Governance Failure
    Covid Handling India's Gravest Governance Failure
    Former Congress chief Rahul Gandhi on Tuesday released the party's 'White Paper' on management of Covid-19, accusing the Central government of not taking adequate measures to prevent and contain the pandemic.
    Experts suggest inoculating kids, teenagers at the earliest
    Experts suggest inoculating kids, teenagers at the earliest
    As studies conducted by the Tamil Nadu State Public Health revealed that the Delta Covid variant has led to a majority of positive cases in the state, experts are of the opinion that children and teenagers should be inoculated against the virus at the earliest after conducting trials.
    Supply of Covaxin to govt at Rs 150/dose not sustainable
    Supply of Covaxin to govt at Rs 150/dose not sustainable
    The supply price of Covaxin to the government of India at Rs 150 a dose is a non-competitive price and clearly not sustainable in the long run.
    STAR Remains Leader Among Broadcasters
    STAR Remains Leader Among Broadcasters
    STAR continued to remain the undoubted leader among broadcasters in May, with group level viewership share of 39.4 per cent, slightly down on high base of IPL viewership in April'21, according to a research by Elara Securities.
    BookMyShow lays off 200 employees amid pandemic woes
    BookMyShow lays off 200 employees amid pandemic woes
    Online ticketing platform BookMyShow has laid off 200 employees as the Covid-19 pandemic continues to affect businesses.
    India's Covid vax policy leading to avertable deaths: Experts
    India's Covid vax policy leading to avertable deaths: Experts
    The Indian government's Covid-19 vaccination approach has inappropriately prioritised people and is thus causing huge numbers of avertable deaths, warn a team of nine experts from research institutes in the UK and India.
    Pfizer's vaccine may cost less than $10 a dose in India
    Pfizer's vaccine may cost less than $10 a dose in India
    US pharmaceutical major Pfizer may price its mRNA-based Covid-19 vaccine, co-developed by BioNTech, below $10 (about Rs 730) a dose in India, sources close to the development indicated.
    India Reports Slight Spike Wed With 93,896 New Cases
    India Reports Slight Spike Wed With 93,896 New Cases
    India's daily Covid-19 cases remained below the 100,000 again today, however, the daily death record saw a massive spike.
    Opinion: Secret Behind The Highest Price Of Covaxin
    Opinion: Secret Behind The Highest Price Of Covaxin
    Entire world is in the vaccination drive to combat Covid-19. Different countries are inoculating their people with respective vaccines.
    India Registers Below 1 Lakh Cases After 68 Days
    India Registers Below 1 Lakh Cases After 68 Days
    India on Monday recorded less than 1 lakh new cases after 68 days while the toll reached below 2,000 after 49 days.
    Free Covid vax to 18 plus age group from June 21: Modi
    Free Covid vax to 18 plus age group from June 21: Modi
    As the second wave of coronavirus has been indicating a declining trend in India for the last few days, Prime Minister Narendra Modi on Monday announced that all Indians above 18 years of age will be administered free Covid-19 vaccine from June 21.
    Covishield Produces More Antibodies than Covaxin
    Covishield Produces More Antibodies than Covaxin
    A study conducted by Coronavirus Vaccine-induced Antibody Titre (COVAT) has found that seropositivity rates and median anti-spike antibody titre was significantly higher in Astra Zeneca’s Covishield as compared to Bharat Biotech’s Covaxin.